HERBAL THERAPY SUPPRESS INTERLEUKIN-1β IN PERIODONTITIS AND TYPE 2 DIABETES MELLITUS
Abstract
Background: Interrelated pathological conditions such as periodontitis and Type 2 Diabetes Mellitus (T2DM) still be the mistery to solve. The production of secondary metabolites due to hyperglycemia conditions, namely AGEs, contributes to inflammation that arises in periodontal tissue. Periodontal inflammation is exacerbated by systemic dysregulation resulting in periodontitis being one of the potential complications aggravating the condition of T2DM. Excessive production of pro-inflammatory cytokines damages periodontal tissue and pancreas B cells and thus leads to insulin resistance. Many approach have been conducted to break the relationship between these two diseases, especially from the inflammatory pathway. Herbal therapy is one of the potential treatment to manage the bidirectional relationship.
Objective: The aim of this study is to elaborate the effects of herbal therapy on decreasing IL-1β cytokines as potential targeted therapeutic targets for both periodontitis and type 2 diabetes condition.
Methods: Literature research done from 2013 to 2023 to find relevant articles.
Result: Several herbal therapies effective in decreased Interleukin-1β and correlated to systemic and periodontal condition.
Conclusion:Herbal therapy is effectively decreasing Interleukin-1β as a potential therapeutic target in periodontitis and Diabetes Mellitus Type 2 management.
Keywords
Full Text:
PDFReferences
Zhou X, Zhang W, Liu X, Zhang W, Li Y. Interrelationship between diabetes and per-iodontitis: Role of hyperlipidemia. Vol. 60, Archives of Oral Biology. 2015.
Prawitasari DS. Diabetes Melitus dan Anti-oksidan. KELUWIH: Jurnal Kesehatan dan Kedokteran. 2019 Dec 17;1(1):48–52.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Di-abetes Res Clin Pract. 2019;157.
Wu YY, Xiao E, Graves DT. Diabetes mellitus related bone metabolism and peri-odontal disease. Vol. 7, International Jour-nal of Oral Science. 2015.
Oguntibeju OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examin-ing the links. Int J Physiol Pathophysiol Pharmacol [Internet]. 2019 [cited 2023 Oct 3];11(3):45. Available from: /pmc/articles/PMC6628012/
Sanz M, Ceriello A, Buysschaert M, Chap-ple I, Demmer RT, Graziani F, et al. Scien-tific evidence on the links between perio-dontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontolo-gy. J Clin Periodontol [Internet]. 2018 Feb 1 [cited 2023 Oct 3];45(2):138–49. Avail-able from: https://pubmed.ncbi.nlm.nih.gov/29280174/
Williams R, Karuranga S, Malanda B, Saeedi P, Basit A, Besançon S, et al. Global and regional estimates and projections of diabetes-related health expenditure: Re-sults from the International Diabetes Fed-eration Diabetes Atlas, 9th edition. Diabe-tes Res Clin Pract [Internet]. 2020 Apr 1 [cited 2023 Oct 3];162. Available from: https://pubmed.ncbi.nlm.nih.gov/32061820/
Landon R, Gueguen V, Petite H, Letourneur D, Pavon-Djavid G, Anagnostou F. Impact of Astaxanthin on Diabetes Pathogenesis and Chronic Complications. Mar Drugs [In-ternet]. 2020 Jul 1 [cited 2023 Oct 3];18(7). Available from: https://pubmed.ncbi.nlm.nih.gov/32660119/
Velikova T V., Kabakchieva PP, Assyov YS, Georgiev TA. Targeting Inflammatory Cytokines to Improve Type 2 Diabetes Control. Biomed Res Int [Internet]. 2021 [cited 2023 Oct 3];2021. Available from: https://pubmed.ncbi.nlm.nih.gov/34557550/
Sanz M, Ceriello A, Buysschaert M, Chap-ple I, Demmer RT, Graziani F, et al. Scien-tific evidence on the links between perio-dontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International diabetes Federation and the European Federation of Periodontolo-gy. Diabetes Res Clin Pract [Internet]. 2018 Mar 1 [cited 2023 Jun 12];137:231–41. Available from: https://pubmed.ncbi.nlm.nih.gov/29208508/
Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis GA, Vogiatzi G, Papaioannou S, et al. The Role of In-flammation in Diabetes: Current Concepts and Future Perspectives. European Cardi-ology Review [Internet]. 2019 [cited 2023 Jun 12];14(1):50. Available from: /pmc/articles/PMC6523054/
Vlassara H, Striker GE. Advanced gly-cation endproducts in diabetes and diabet-ic complications. Endocrinol Metab Clin North Am [Internet]. 2013 Dec [cited 2023 Oct 3];42(4):697–719. Available from: https://pubmed.ncbi.nlm.nih.gov/24286947/
Xie J, Méndez JD, Méndez-Valenzuela V, Aguilar-Hernández MM. Cellular signal-ling of the receptor for advanced glycation end products (RAGE). Cell Signal [Inter-net]. 2013 Nov [cited 2023 Oct 3];25(11):2185–97. Available from: https://pubmed.ncbi.nlm.nih.gov/23838007/
Chopra A, Jayasinghe TN, Eberhard J. Are Inflamed Periodontal Tissues Endogenous Source of Advanced Glycation End-Products (AGEs) in Individuals with and without Diabetes Mellitus? A Systematic Review. Biomolecules [Internet]. 2022 May 1 [cited 2023 Oct 3];12(5). Available from: /pmc/articles/PMC9138899/
Khumaedi AI, Purnamasari D, Wijaya IP, Soeroso Y. The relationship of diabetes, periodontitis and cardiovascular disease. Diabetes Metab Syndr [Internet]. 2019 Mar 1 [cited 2023 Oct 3];13(2):1675–8. Avail-able from: https://pubmed.ncbi.nlm.nih.gov/31336540/
Sanz M, Ceriello A, Buysschaert M, Chap-ple I, Demmer RT, Graziani F, et al. Scien-tific evidence on the links between perio-dontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International diabetes Federation and the European Federation of Periodontolo-gy. Diabetes Res Clin Pract [Internet]. 2018 Mar 1 [cited 2023 Jul 6];137:231–41. Available from: https://pubmed.ncbi.nlm.nih.gov/29208508/
Graves DT, Ding Z, Yang Y. The impact of diabetes on periodontal diseases. Vol. 82, Periodontology 2000. 2020.
Huang X, Yang X, Ni J, Xie B, Liu Y, Xuan D, et al. Hyperglucose contributes to peri-odontitis: involvement of the NLRP3 pathway by engaging the innate immunity of oral gingival epithelium. J Periodontol [Internet]. 2015 Feb [cited 2023 Oct 3];86(2):327–35. Available from: https://pubmed.ncbi.nlm.nih.gov/25325516/
Jiao H, Xiao E, Graves DT. Diabetes and Its Effect on Bone and Fracture Healing. Curr Osteoporos Rep [Internet]. 2015 Oct 7 [cit-ed 2023 Oct 3];13(5):327–35. Available from: https://pubmed.ncbi.nlm.nih.gov/26254939/
Marin C, Luyten FP, Van der Schueren B, Kerckhofs G, Vandamme K. The Impact of Type 2 Diabetes on Bone Fracture Healing. Front Endocrinol (Lausanne) [Internet]. 2018 Jan 24 [cited 2023 Oct 3];9(JAN). Available from: https://pubmed.ncbi.nlm.nih.gov/29416527/
Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol [Internet]. 2014 May 19 [cited 2023 Oct 3];24(10). Available from: https://pubmed.ncbi.nlm.nih.gov/24845678/
Luc K, Schramm-Luc A, Guzik TJ, Mikola-jczyk TP. Oxidative stress and inflammato-ry markers in prediabetes and diabetes. J Physiol Pharmacol [Internet]. 2019 Dec 1 [cited 2023 Oct 3];70(6). Available from: https://pubmed.ncbi.nlm.nih.gov/32084643/
Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis GA, Vogiatzi G, Papaioannou S, et al. The Role of In-flammation in Diabetes: Current Concepts and Future Perspectives. Eur Cardiol [In-ternet]. 2019 [cited 2023 Oct 3];14(1):50–9. Available from: https://pubmed.ncbi.nlm.nih.gov/31131037/
Kousathana F, Georgitsi M, Lambadiari V, Giamarellos-Bourboulis EJ, Dimitriadis G, Mouktaroudi M. Defective production of interleukin-1 beta in patients with type 2 diabetes mellitus: Restoration by proper glycemic control. Cytokine [Internet]. 2017 Feb 1 [cited 2023 Oct 3];90:177–84. Available from: https://pubmed.ncbi.nlm.nih.gov/27918955/
Jiang ZL, Cui YQ, Gao R, Li Y, Fu ZC, Zhang B, et al. Study of TNF-α, IL-1β and LPS levels in the gingival crevicular fluid of a rat model of diabetes mellitus and per-iodontitis. Dis Markers [Internet]. 2013 [cited 2023 Oct 3];34(5):295–304. Availa-ble from: https://pubmed.ncbi.nlm.nih.gov/23478270/
Rangbulla V, Nirola A, Gupta M, Batra P, Gupta M. Salivary IgA, Interleukin-1β and MMP-8 as Salivary Biomarkers in Chronic Periodontitis Patients. The Chinese journal of dental research [Internet]. 2017 Jan 1 [cited 2023 Oct 3];20(1):43–51. Available from: https://pubmed.ncbi.nlm.nih.gov/28232966/
ABDULLAMEER MA, ABDULKAREEM AA. Salivary interleukin-1β as a biomarker to differentiate between periodontal health, gingivitis, and periodontitis. Minerva den-tal and oral science [Internet]. 2023 May [cited 2023 Oct 3]; Available from: https://pubmed.ncbi.nlm.nih.gov/37162330/
Zhang Z, Liu S, Zhang S, Li Y, Shi X, Liu D, et al. Porphyromonas gingivalis outer membrane vesicles inhibit the invasion of Fusobacterium nucleatum into oral epithe-lial cells by downregulating FadA and Fo-mA. J Periodontol. 2022;93(4).
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA ex-tension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann In-tern Med [Internet]. 2018 Oct 2 [cited 2025 Jan 9];169(7):467–73. Available from: https://www.acpjournals.org/doi/10.7326/M18-0850
Levac D, Colquhoun H, O’Brien KK. Scop-ing studies: Advancing the methodology. Implementation Science [Internet]. 2010 Sep 20 [cited 2025 Jan 9];5(1):1–9. Avail-able from: https://link.springer.com/articles/10.1186/1748-5908-5-69
Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol [Internet]. 2005 Feb [cited 2025 Jan 9];8(1):19–32. Available from: https://www.tandfonline.com/doi/abs/10.1080/1364557032000119616
Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Camp-bell systematic reviews [Internet]. 2022 Jun 1 [cited 2025 Jan 8];18(2). Available from: https://pubmed.ncbi.nlm.nih.gov/36911350/
Harikrishnan H, Jantan I, Haque A, Kumo-losasi E. Anti-inflammatory effects of Phyllanthus amarus Schum. & Thonn. through inhibition of NF-κB, MAPK, and PI3K-Akt signaling pathways in LPS-induced human macrophages. [cited 2025 Jan 8]; Available from: https://doi.org/10.1186/s12906-018-2289-3
Choi KH, Hong J, Kim KY, Kim H, Lee S, Lee Y, et al. Anti-Inflammatory Properties of MSF, a Lactiplantibacillus plantarum K8 Lysate Fermented with Filipendula glaber-rima Extract. Applied Sciences 2022, Vol 12, Page 2602 [Internet]. 2022 Mar 2 [cited 2025 Jan 8];12(5):2602. Available from: https://www.mdpi.com/2076-3417/12/5/2602/htm
Alanazi AZ, Al-Rejaie SS, Ahmed MM, Alhazzani K, Alhosaini K, As Sobeai HM, et al. Protective role of Dodonaea viscosa extract against streptozotocin-induced hepatotoxicity and nephrotoxicity in rats. Saudi Pharmaceutical Journal. 2023 Aug 1;31(8):101669.
Zhang B, Yue R, Chen Y, Huang X, Yang M, Shui J, et al. The Herbal Medicine Scu-tellaria-Coptis Alleviates Intestinal Muco-sal Barrier Damage in Diabetic Rats by In-hibiting Inflammation and Modulating the Gut Microbiota. Evid Based Complement Alternat Med [Internet]. 2020 [cited 2025 Jan 8];2020. Available from: https://pubmed.ncbi.nlm.nih.gov/33224253/
Ryuk JA, Ko BS, Lee HW, Kim DS, Kang S, Lee YH, et al. Tetragonia tetragonioides (Pall.) Kuntze protects estrogen-deficient rats against disturbances of energy and glucose metabolism and decreases proin-flammatory cytokines. Exp Biol Med (Maywood) [Internet]. 2017 Mar 1 [cited 2025 Jan 8];242(6):593–605. Available from: https://pubmed.ncbi.nlm.nih.gov/28241734/
Li J, Li N, Yan S, Liu M, Sun B, Lu Y, et al. Ursolic acid alleviates inflammation and against diabetes induced nephropathy through TLR4 mediated inflammatory pathway. Mol Med Rep [Internet]. 2018 Nov 1 [cited 2025 Jan 8];18(5):4675–81. Available from: https://pubmed.ncbi.nlm.nih.gov/30221655/
Hu Y, Lei S, Yan Z, Hu Z, Guo J, Guo H, et al. Angelica Dahurica Regulated the Polar-ization of Macrophages and Accelerated Wound Healing in Diabetes: A Network Pharmacology Study and In Vivo Experi-mental Validation. Front Pharmacol [Inter-net]. 2021 Jun 21 [cited 2025 Jan 8];12. Available from: https://pubmed.ncbi.nlm.nih.gov/34234674/
Sha AM, Garib BT, Azeez SH, Gul SS. Ef-fects of curcumin gel on osteoclastogenic bone markers in experimental periodontitis and alveolar bone loss in wistar rats. J Dent Sci [Internet]. 2021 Jul 1 [cited 2025 Jan 8];16(3):905–14. Available from: https://pubmed.ncbi.nlm.nih.gov/34141104/
Ahmad B, Rehman MU, Amin I, Mir M ur R, Ahmad SB, Farooq A, et al. Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced dia-betes via alleviation of oxidative stress and inflammation: Probable role of NF-kB ac-tivation. Saudi Pharmaceutical Journal. 2018 Dec 1;26(8):1137–45.
Pollack RM, Donath MY, LeRoith D, Leibowitz G. Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications. Diabetes Care [Internet]. 2016 Aug 1 [cited 2023 Oct 3];39 Suppl 2:S244–52. Available from: https://pubmed.ncbi.nlm.nih.gov/27440839/
Ruscitti P, Cipriani P, Cantarini L, Liakouli V, Vitale A, Carubbi F, et al. Efficacy of inhibition of IL-1 in patients with rheuma-toid arthritis and type 2 diabetes mellitus: two case reports and review of the litera-ture. J Med Case Rep [Internet]. 2015 Jun 2 [cited 2023 Oct 3];9(1). Available from: https://pubmed.ncbi.nlm.nih.gov/26033326/
Everett BM, Cornel JH, Lainscak M, Anker SD, Abbate A, Thuren T, et al. Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure. Circulation [Internet]. 2019 Mar 5 [cited 2023 Oct 3];139(10):1289–99. Available from: https://pubmed.ncbi.nlm.nih.gov/30586730/
Dinarello CA, van der Meer JWM. Treating inflammation by blocking interleukin-1 in humans. Semin Immunol [Internet]. 2013 Dec 15 [cited 2023 Oct 3];25(6):469–84. Available from: https://pubmed.ncbi.nlm.nih.gov/24275598/
Kataria Y, Ellervik C, Mandrup-Poulsen T. Treatment of type 2 diabetes by targeting interleukin-1: a meta-analysis of 2921 pa-tients. Semin Immunopathol [Internet]. 2019 Jul 1 [cited 2023 Oct 3];41(4):413–25. Available from: https://pubmed.ncbi.nlm.nih.gov/31025084/
Jeong-Hyon K, Bon-Hyuk G, Sang-Soo N, Yeon-Cheol P. A review of rat models of periodontitis treated with natural extracts. Journal of Traditional Chinese Medical Sciences. 2020 Apr 1;7(2):95–103.
Dinarello CA, van der Meer JWM. Treating inflammation by blocking interleukin-1 in humans. Semin Immunol [Internet]. 2013 Dec 15 [cited 2023 Oct 3];25(6):469–84. Available from: https://pubmed.ncbi.nlm.nih.gov/24275598/
Aharon-Hananel G, Jörns A, Lenzen S, Raz I, Weksler-Zangen S. Antidiabetic Effect of Interleukin-1β Antibody Therapy Through β-Cell Protection in the Cohen Diabetes-Sensitive Rat. Diabetes [Internet]. 2015 May 1 [cited 2023 Oct 3];64(5):1780–5. Available from: https://dx.doi.org/10.2337/db14-1018
Goh AXH, Bertin-Maghit S, Yeo SP, Ho AWS, Derks H, Mortellaro A, et al. A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo effi-cacy. MAbs [Internet]. 2014 [cited 2023 Oct 3];6(3):764–72. Available from: https://pubmed.ncbi.nlm.nih.gov/24671001/
Cheng R, Wu Z, Li M, Shao M, Hu T. Inter-leukin-1β is a potential therapeutic target for periodontitis: a narrative review. Vol. 12, International Journal of Oral Science. 2020.
Javed F, Al-Daghri NM, Wang HL, Wang CY, Al-Hezaimi K. Short-term effects of non-surgical periodontal treatment on the gingival crevicular fluid cytokine profiles in sites with induced periodontal defects: a study on dogs with and without strepto-zotocin-induced diabetes. J Periodontol [Internet]. 2014 Nov [cited 2023 Oct 3];85(11):1589–95. Available from: https://pubmed.ncbi.nlm.nih.gov/24835413/
Rabelo M de S, Gomes GH, Foz AM, Stadler AF, Cutler CW, Susin C, et al. Short-term effect of non-surgical periodon-tal treatment on local and systemic cyto-kine levels: Role of hyperglycemia. Cyto-kine [Internet]. 2021 Feb 1 [cited 2023 Oct 3];138. Available from: https://pubmed.ncbi.nlm.nih.gov/33221157/
Bazyar H, Maghsoumi-Norouzabad L, Yarahmadi M, Gholinezhad H, Moradi L, Salehi P, et al. The Impacts of Synbiotic Supplementation on Periodontal Indices and Biomarkers of Oxidative Stress in Type 2 Diabetes Mellitus Patients with Chronic Periodontitis Under Non-Surgical Periodontal Therapy. A Double-Blind, Pla-cebo-Controlled Trial. Diabetes Metab Syndr Obes [Internet]. 2020 [cited 2023 Oct 3];13:19–29. Available from: https://pubmed.ncbi.nlm.nih.gov/32021348/
Ng MY, Lin T, Chao SC, Chu PM, Yu CC. Potential Therapeutic Applications of Nat-ural Compounds in Diabetes-Associated Periodontitis. J Clin Med [Internet]. 2022 Jul 1 [cited 2023 Oct 16];11(13). Available from: https://pubmed.ncbi.nlm.nih.gov/35806899/
Xiao CJ, Yu XJ, Xie JL, Liu S, Li S. Protec-tive effect and related mechanisms of cur-cumin in rat experimental periodontitis. Head Face Med [Internet]. 2018 Aug 16 [cited 2023 Oct 16];14(1). Available from: https://pubmed.ncbi.nlm.nih.gov/30115081/
Sha AM, Garib BT, Azeez SH, Gul SS. Ef-fects of curcumin gel on osteoclastogenic bone markers in experimental periodontitis and alveolar bone loss in wistar rats. J Dent Sci. 2021 Jul 1;16(3):905–14.
DOI: https://doi.org/10.33854/jbd.v12i1.1764
DOI (PDF): https://doi.org/10.33854/jbd.v12i1.1764.g620
Refbacks
- There are currently no refbacks.
Copyright (c) 2025 Lastry Ruth Padang, Ahmad Syaify, Vincensia Maria Karina
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.